Webinars for clinicians on needs of vulnerable respiratory
Webinars with more than 1,000 HCPs to provide an update on prevention and treatment recommendations for vulnerable respiratory patients. Learn more here.
Search
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
Type 2 Diabetes and Risk of Viral Infections
In the current COVID-19 climate, it’s important for everyone to stay safe at home, particularly people living with conditions such as type-2 diabetes.
Science against COVID-19 fake news and misinformation
As there is no evidence that animals can transmit COVID-19, the livestock community highlights information to join the battle against false claims.
COVID-19 Protecting Our Employees
We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
1948-1988
Following the death of Albert Boehringer (1861-1939), his two sons and his son-in-law Julius Liebrecht took over this family company. Learn more.
1988-2015
Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
Harold Heart and Friends
The cardiovascular, renal and metabolic systems are interconnected and dysfunction in one system may lead to dysfunction in the other. Learn more here.
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
Innovation Through Cooperation
Exchange of information between pharmaceutical manufacturers and healthcare professionals is essential for patients. Click here to learn more.
COVID-19 Learning from the pandemic
Online training options develop vets and other animal health professionals’ skills helping them overcome movement restrictions to thrive around the globe.
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
COVID-19 Ivermectin Animal Health Not for Human Use
BI manufactures several veterinary products containing ivermectin. They are not approved or suitable for use in humans to try to prevent or treat COVID-19.
EMPRISE
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care. Click here to find out more information.
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management. Click here to find out more information.
Guardians for health
A global initiative to reduce mortality, cardiovascular and kidney complications in type 2 diabetes through adherence to clinical guidelines. Learn more.
Cat care interview veterinarian Dr Susan Little
We interviewed world-renowned feline healthcare specialist Dr Susan Little to get her thoughts on cat care. Click here to read and find out more.
Pet industry trends Millennials
Millennials are now shaping pet markets and facing new issues in pet healthcare. Click here to read and learn more about this new generation of pet owners.
COVID-19 Boehringer Ingelheim NL donates 440 oxygen meters
Boehringer Ingelheim donates 440 oxygen meters to lung specialists and general practitioners during the pandemic. Click here to find out more.
Technical Center for Veterinary Equipment in Russia
Boehringer Ingelheim opened a new Technical Support Centre for Veterinary Equipment in Russia. Click here to find out and learn more information.
COVID-19 Mexico - The value of teamwork
During the pandemic, Fabiola Villegas, contributed with creativity and ingenuity from her region in Uruapan, Michoacán, Mexico. Click here to learn more.
COVID-19 USA Double the Impact in the Fight Against COVID-19
Employees can double their impact through the BI Cares Matching Gifts Program. Click here to learn and find out more information about this.
Lyon
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Lyon site.
Innovation Needs Transparency
At Boehringer Ingelheim, we prioritise the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture.
One step further in fighting rabies in Vietnam
A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages. Find out more.ral villages.